Skip to main content
PAINWeek 2024 Main banner
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it
Back

Product Theater

PDM-01 - From Evidence to Practice: New Results from a 1-Year Real-World Study Supporting Use of Topical Capsaicin for Painful Diabetic Peripheral Neuropathy of the Feet

Tuesday, September 3, 2024
8:30 AM – 9:30 AM PST
Location:  Chelsea Theater

Sponsored By Averitas Pharma 

    Co-Presenter(s)

  • Michael M. Bottros, MD

    Chief Clinical Operations and Medical Director for Pain Services
    Keck School of Medicine of the University of Southern California
    Bradbury, California

  • Michael Uberall, MD

    Medical Director
    Institute of Neurological Sciences
    Nuremberg, Bayern, Germany

Join us at an upcoming symposium, sponsored by Averitas Pharma, which will feature two leading experts in the pain management community, who will unveil new 1-year real-world evidence (RWE) data for treating painful diabetic peripheral neuropathy (DPN) of the feet with topical capsaicin. This RWE helps bridge the data gap between short-term controlled clinical studies and the long-term real-world use of topical capsaicin in treating painful DPN. Attendees will gain valuable insights into this nonsystemic treatment approach and how it can be integrated into clinical practice to reduce pain. This symposium aims to educate healthcare professionals on the mechanism of action, practical knowledge, and latest clinical data supporting the use of topical capsaicin to enhance the care of patients suffering from painful DPN of the feet.

Breakfast will be provided. Not certified for credit.